US Patent 7585893 Anti-cancer composition comprising DMXAA or related compound
Patent 7585893 was granted and assigned to Cancer Research Technology Limited on September, 2009 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
April 28, 2005
0
Date of Patent
September 8, 2009
0
Patent Application Number
11116798
0
Patent Inventor Names
Bruce Charles Baguley
0
Philip Kestell
0
Liangli Zhao
0
Lai-Ming Ching
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 7585893 Anti-cancer composition comprising DMXAA or related compound
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.